Translocations (5;17) and (7;17) in patients with de novo or therapy-related myelodysplastic syndromes or acute nonlymphocytic leukemia
- 1 June 1990
- journal article
- research article
- Published by Elsevier in Cancer Genetics and Cytogenetics
- Vol. 46 (2), 173-183
- https://doi.org/10.1016/0165-4608(90)90102-g
Abstract
No abstract availableThis publication has 38 references indexed in Scilit:
- Recommendations for a morphologic, immunologic, and cytogenetic (MIC) working classification of the primary and therapy-related myelodysplastic disordersCancer Genetics and Cytogenetics, 1988
- Refined chromosome study helps define prognostic subgroups in most patients with primary myelodysplastic syndrome and acute myelogenous leukaemiaBritish Journal of Haematology, 1988
- Cytogenetic studies in patients with secondary leukemia/dysmyelopoietic syndrome after different treatment modalitiesBlood, 1988
- Refined chromosome analysis as an independent prognostic indicator in de novo myelodysplastic syndromesBlood, 1986
- Prognostic implications of morphology and karyotype in primary myelodysplastic syndromesBlood, 1986
- Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7.Journal of Clinical Oncology, 1986
- Refractory dysmyelopoietic anemia and acute leukemiaBlood, 1984
- Cytogenetic study of 88 cases of refractory anemiaCancer Genetics and Cytogenetics, 1983
- Proposals for the classification of the myelodysplastic syndromesBritish Journal of Haematology, 1982
- The preleukemic syndrome (hemopoietic dysplasia)Cancer, 1978